Noori Alireza, Ashrafi Seyed Jamal, Vaez-Ghaemi Roza, Hatamian-Zaremi Ashraf, Webster Thomas J
Department of Tissue Engineering and Applied Cell Sciences, Faculty of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran.
School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.
Int J Nanomedicine. 2017 Jul 12;12:4937-4961. doi: 10.2147/IJN.S124671. eCollection 2017.
Tissue engineering has emerged as a new treatment approach for bone repair and regeneration seeking to address limitations associated with current therapies, such as autologous bone grafting. While many bone tissue engineering approaches have traditionally focused on synthetic materials (such as polymers or hydrogels), there has been a lot of excitement surrounding the use of natural materials due to their biologically inspired properties. Fibrin is a natural scaffold formed following tissue injury that initiates hemostasis and provides the initial matrix useful for cell adhesion, migration, proliferation, and differentiation. Fibrin has captured the interest of bone tissue engineers due to its excellent biocompatibility, controllable biodegradability, and ability to deliver cells and biomolecules. Fibrin is particularly appealing because its precursors, fibrinogen, and thrombin, which can be derived from the patient's own blood, enable the fabrication of completely autologous scaffolds. In this article, we highlight the unique properties of fibrin as a scaffolding material to treat bone defects. Moreover, we emphasize its role in bone tissue engineering nanocomposites where approaches further emulate the natural nanostructured features of bone when using fibrin and other nanomaterials. We also review the preparation methods of fibrin glue and then discuss a wide range of fibrin applications in bone tissue engineering. These include the delivery of cells and/or biomolecules to a defect site, distributing cells, and/or growth factors throughout other pre-formed scaffolds and enhancing the physical as well as biological properties of other biomaterials. Thoughts on the future direction of fibrin research for bone tissue engineering are also presented. In the future, the development of fibrin precursors as recombinant proteins will solve problems associated with using multiple or single-donor fibrin glue, and the combination of nanomaterials that allow for the incorporation of biomolecules with fibrin will significantly improve the efficacy of fibrin for numerous bone tissue engineering applications.
组织工程学已成为一种用于骨修复和再生的新型治疗方法,旨在解决与当前疗法(如自体骨移植)相关的局限性。虽然传统上许多骨组织工程方法都集中在合成材料(如聚合物或水凝胶)上,但由于天然材料具有受生物启发的特性,围绕其使用产生了很多令人兴奋的研究。纤维蛋白是组织损伤后形成的一种天然支架,可启动止血并提供有助于细胞黏附、迁移、增殖和分化的初始基质。纤维蛋白因其优异的生物相容性、可控的生物降解性以及递送细胞和生物分子的能力,引起了骨组织工程师的关注。纤维蛋白特别有吸引力,因为其前体纤维蛋白原和凝血酶可从患者自身血液中获取,从而能够制造完全自体的支架。在本文中,我们重点介绍纤维蛋白作为治疗骨缺损的支架材料的独特特性。此外,我们强调其在骨组织工程纳米复合材料中的作用,即在使用纤维蛋白和其他纳米材料时,这些方法能进一步模拟骨的天然纳米结构特征。我们还回顾了纤维蛋白胶的制备方法,然后讨论纤维蛋白在骨组织工程中的广泛应用。这些应用包括将细胞和/或生物分子递送至缺损部位、在其他预制支架中分布细胞和/或生长因子,以及增强其他生物材料的物理和生物学特性。本文还提出了关于骨组织工程中纤维蛋白研究未来方向的思考。未来,将纤维蛋白前体开发为重组蛋白将解决与使用多供体或单供体纤维蛋白胶相关的问题,并且允许将生物分子与纤维蛋白结合的纳米材料组合将显著提高纤维蛋白在众多骨组织工程应用中的功效。